Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|September 1, 1974
Granulocyte transfusion therapy of experimental Pseudomonas pneumoniaD C Dale, H Y Reynolds, J E Pennington, et al.
Arthritis and Rheumatism|May 1, 1976
Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean feverC A Dinarello, M J Chusid, A S Fauci, et al.
Blood|November 14, 1997
Chronic thrombocytopenia is induced in dogs by development of cross-reacting antibodies to the MpL ligandD C Dale, J L Nichol, D A Rich, et al.
Cytokines, Cellular & Molecular Therapy|January 5, 2001
Inhibition of in vivo neutrophil transmigration by a novel humanized anti-CD11/CD18 monoclonal antibodyW C Liles, D C Dale, T H Price, et al.
Blood|November 9, 2000
Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropeniaS Jeha, K W Chan, A G Aprikyan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2013
The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trialsG H Lyman, D C Dale, E Culakova, et al.
Clinical Pharmacology and Therapeutics|May 19, 2005
A pharmacokinetic-pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100N A Lack, B Green, D C Dale, et al.
Blood|May 15, 1993
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropeniaD C Dale, M A Bonilla, M W Davis, et al.
Clinical Pharmacology and Therapeutics|October 3, 1998
Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosisJ D Bowen, S H Petersdorf, T L Richards, et al.
Blood|April 1, 1993
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresisW I Bensinger, T H Price, D C Dale, et al.
Pageof 12